We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Tom Hockaday, Managing Director of Oxford University Innovation has been announced as joint winner of the Bridge Award at the inaugural Academic Enterprise Awards 2008.
Oxford University Innovation, the University of Oxford’s technology transfer company, announced today that a new spin-out company has been formed based on technology developed at the University. Intelligent Sustainable Energy (ISE) has received funding from Navetas Energy Management to develop a smart metering technology.
Chemists at the University of Oxford have developed a hydrogen fuel cell which uses enzymes to catalyse the reactions on electrodes, producing electricity.
A novel solid-state pH sensor technology invented at the University of Oxford is to be further developed and commercialised by San Francisco Bay Area based company Phathom Nanosensors Inc.
The Masdar Initiative in Abu Dhabi is one of the most exciting projects underway in the world.
12 August 2008 - Update. More information on the Boots Centre for Innovation, New Product Innovation events is available on their website.
Oxford researchers have developed a software package which significantly improves the accuracy of genetic analysis critical in revealing information about susceptibility to different diseases and in developing new diagnostic technologies.
An Oxford University spin-out company, due to launch later this year, has won praise for its smart meter technology from Shadow Chancellor George Osborne.
Despite considerable advances over recent decades, cancer, and many other diseases remain poorly treated. Many therapeutic regimes frequently subject the sufferer to severe side-effects, and resistance often develops to therapies that are initially effective. For many illnesses, the life-expectance upon diagnosis is depressingly short. There is an urgent need for new, more effective, therapeutic options.
Emergent Biosolutions and the University of Oxford form joint venture to develop an advanced tuberculosis vaccine with funding from Wellcome Trust and Aeras Global TB Vaccine Foundation.
